Gill Anlezark

1.5k total citations
29 papers, 1.2k citations indexed

About

Gill Anlezark is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Gill Anlezark has authored 29 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Cellular and Molecular Neuroscience, 8 papers in Molecular Biology and 7 papers in Psychiatry and Mental health. Recurrent topics in Gill Anlezark's work include Neuroscience and Neuropharmacology Research (12 papers), Epilepsy research and treatment (7 papers) and Ion channel regulation and function (3 papers). Gill Anlezark is often cited by papers focused on Neuroscience and Neuropharmacology Research (12 papers), Epilepsy research and treatment (7 papers) and Ion channel regulation and function (3 papers). Gill Anlezark collaborates with scholars based in United Kingdom, United States and Poland. Gill Anlezark's co-authors include Brian S. Meldrum, Timothy J. Crow, Roger W. Horton, A. P. Greenway, B.S. Meldrum, Bassel E. Sawaya, Nigel P. Minton, C Pycock, John K. Brehm and C. D. Marsden and has published in prestigious journals such as Nature, Science and Brain.

In The Last Decade

Gill Anlezark

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gill Anlezark United Kingdom 17 631 361 328 180 163 29 1.2k
L.J. Fowler United Kingdom 20 682 1.1× 542 1.5× 183 0.6× 129 0.7× 83 0.5× 38 1.4k
Helen M. Chao United States 26 401 0.6× 525 1.5× 108 0.3× 82 0.5× 142 0.9× 41 1.7k
Theodore A. Hare United States 22 691 1.1× 368 1.0× 237 0.7× 78 0.4× 95 0.6× 46 1.4k
R. Tyler McCabe United States 24 1.3k 2.0× 979 2.7× 295 0.9× 86 0.5× 193 1.2× 43 1.9k
S.T.M. Allard Canada 22 468 0.7× 634 1.8× 96 0.3× 34 0.2× 169 1.0× 39 1.6k
James A. Totaro United States 19 730 1.2× 458 1.3× 98 0.3× 48 0.3× 96 0.6× 34 1.4k
Junichi Nomura Japan 19 514 0.8× 333 0.9× 73 0.2× 24 0.1× 145 0.9× 46 1.5k
Peter Pörzgen United States 16 420 0.7× 375 1.0× 74 0.2× 34 0.2× 29 0.2× 23 1.1k
Duk‐Soo Kim South Korea 22 569 0.9× 783 2.2× 214 0.7× 87 0.5× 145 0.9× 96 1.7k
T.A. Hare United States 16 530 0.8× 235 0.7× 182 0.6× 64 0.4× 84 0.5× 34 1.0k

Countries citing papers authored by Gill Anlezark

Since Specialization
Citations

This map shows the geographic impact of Gill Anlezark's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gill Anlezark with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gill Anlezark more than expected).

Fields of papers citing papers by Gill Anlezark

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gill Anlezark. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gill Anlezark. The network helps show where Gill Anlezark may publish in the future.

Co-authorship network of co-authors of Gill Anlezark

This figure shows the co-authorship network connecting the top 25 collaborators of Gill Anlezark. A scholar is included among the top collaborators of Gill Anlezark based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gill Anlezark. Gill Anlezark is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Theys, Jan, Oliver Pennington, Ludwig J. Dubois, et al.. (2006). Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivo. British Journal of Cancer. 95(9). 1212–1219. 98 indexed citations
3.
Anlezark, Gill, Roger G. Melton, Roger F. Sherwood, et al.. (1995). Bioactivation of dinitrobenzamide mustards by an E. coli B nitroreductase. Biochemical Pharmacology. 50(5). 609–618. 73 indexed citations
4.
Brehm, John K., et al.. (1994). Physical characterisation of the Escherichia coli B gene encoding nitroreductase and its over-expression in Escherichia coli K12. FEMS Microbiology Letters. 124(2). 195–202. 53 indexed citations
5.
Anlezark, Gill, Douglas Blackwood, Brian S. Meldrum, Vishnu Ji Ram, & John L. Neumeyer. (1983). Comparative assessment of dopamine agonist aporphines as anticonvulsants in two models of reflex epilepsy. Psychopharmacology. 81(2). 135–139. 8 indexed citations
6.
Meldrum, Brian S., Gill Anlezark, H. K. Adam, & D. T. Greenwood. (1982). Anticonvulsant and proconvulsant properties of viloxazine hydrochloride: Pharmacological and pharmacokinetic studies in rodents and the epileptic baboon. Psychopharmacology. 76(3). 212–217. 31 indexed citations
7.
Neumeyer, John L., Say‐Jong Law, Brian S. Meldrum, Gill Anlezark, & Keith J. Watling. (1981). Aporphines. 34. (-)-2,10,11-Trihydroxy-N-n-propylnoraporphine, a novel dopaminergic aporphine alkaloid with anticonvulsant activity. Journal of Medicinal Chemistry. 24(7). 898–899. 11 indexed citations
8.
Anlezark, Gill, et al.. (1981). Dopamine Agonists in Reflex Epilepsy. 251–262. 18 indexed citations
9.
Horton, Roger W., Gill Anlezark, & Brian S. Meldrum. (1980). Noradrenergic influences on sound-induced seizures.. Journal of Pharmacology and Experimental Therapeutics. 214(2). 437–442. 49 indexed citations
10.
Anlezark, Gill, et al.. (1977). Seizure activity in photosensitive baboons following antidepressant drugs and the role of serotoninergic mechanisms. Psychopharmacology. 51(2). 159–164. 40 indexed citations
11.
Anlezark, Gill, et al.. (1977). DOPAMINE AGONISTS AND REFLEX EPILEPSY. Abstracts. 19. 301–301. 8 indexed citations
12.
Horton, Roger W., et al.. (1977). Monoamine and GABA metabolism and the anticonvulsant action of DI-n-propylacetate and ethanolamine-O-sulphate. European Journal of Pharmacology. 41(4). 387–397. 94 indexed citations
13.
Anlezark, Gill, et al.. (1976). Proceedings: gamma-Aminobutyric acid metabolism and the anticonvulsant action of ethanolamine-o-sulphate and di-n-propylacetate.. PubMed Central. 56(3). 383P–384P. 6 indexed citations
14.
15.
Anlezark, Gill, et al.. (1976). Inhibition of reflex epilepsy by (±)-N-n-propylnorapomorphine. European Journal of Pharmacology. 39(2). 399–401. 12 indexed citations
16.
Meldrum, Brian S., et al.. (1975). Drugs modifying dopaminergic activity and behaviour, the EEG and epilepsy in Papio papio. European Journal of Pharmacology. 32(2). 203–213. 73 indexed citations
17.
Bs, Meldrum, et al.. (1975). Photically induced epilepsy in Papio papio as a model for drug studies.. PubMed. 10. 119–32. 30 indexed citations
18.
Anlezark, Gill & Brian S. Meldrum. (1975). EFFECTS OF APOMORPHINE, ERGOCORNINE AND PIRIBEDIL ON AUDIOGENIC SEIZURES IN DBA/2 MICE. British Journal of Pharmacology. 53(3). 419–421. 39 indexed citations
19.
Anlezark, Gill, Timothy J. Crow, & A. P. Greenway. (1973). Impaired Learning and Decreased Cortical Norepinephrine after Bilateral Locus Coeruleus Lesions. Science. 181(4100). 682–684. 209 indexed citations
20.
Anlezark, Gill, Gordon W. Arbuthnott, Timothy J. Crow, D. Eccleston, & D.S. Walter. (1973). Intracranial self-stimulation and noradrenaline metabolism in cortex.. PubMed. 47(3). 645P–645P. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026